 This study found that succubitrile-slash-valsartin-S-slash-V, a combination therapy for heart failure, can lead to reversal of cardiac remodeling in some patients. The study also showed that patients with better heart function had higher chances of experiencing this beneficial effect. Furthermore, the study found that patients with reduced right ventricle function experienced greater improvement in their right ventricles than those with normal right ventricle function. This article was authored by Federica Valley, Francesca Bersi, Gloria Santangelo, and others.